1 Min Read
* Endo announces U.S. FDA approval of ephedrine sulfate injection, USP
* Endo International Plc says Par Pharmaceutical expects to start ephedrine sulfate injection shipping in February 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.